A comprehensive review emphasizes how dynamic interactions between cancer cells, immune cells, and stromal components shape metastatic niches, particularly in immune-privileged sites like the brain.[24] This framework supports our findings on AGO3, as its dysregulation may contribute to immune evasion and niche adaptation in BM. This evidence concerns the gene AGO3 and cancer.